| In millions, except per share items | Aug-31-23 | Nov-30-22 | Aug-31-22 | May-31-22 | Feb-28-22 | Nov-30-21 | Aug-31-21 | May-31-21 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues: |
| Cannabis | | | | 53.3 | 55.0 | | | 53.7 |
| Other | | | | 100.1 | 96.8 | | | 88.5 |
| Total revenues | 176.9 | 144.1 | 153.2 | 153.3 | 151.9 | 155.2 | 168.0 | 142.2 |
| Revenue growth [+] | 15.5% | -7.1% | -8.8% | 7.8% | 22.6% | 19.8% | 43.0% | 25.3% |
| Cannabis | | | | -0.8% | 31.9% | | | |
| Cost of goods sold | 132.8 | 104.0 | 104.6 | 117.1 | 121.3 | 122.4 | 117.1 | 89.4 |
| Gross profit | 44.2 | 40.1 | 48.6 | 36.2 | 30.6 | 32.8 | 51.0 | 52.9 |
| Gross margin | 25.0% | 27.8% | 31.7% | 23.6% | 20.1% | 21.1% | 30.3% | 37.2% |
| Selling, general and administrative [+] | 70.1 | 71.2 | 73.2 | 77.3 | 69.8 | 58.9 | 78.5 | 57.3 |
| Sales and marketing | 15.4 | 18.2 | 16.9 | 20.4 | 16.2 | 16.3 | 12.9 | 13.6 |
| General and administrative [+] | 54.7 | 53.0 | 56.3 | 56.9 | 53.6 | 42.6 | 65.6 | 43.7 |
| Wages and related expenses | 13.1 | 10.2 | 14.6 | 14.2 | 14.1 | 8.1 | 15.3 | 10.1 |
| General and administrative expenses | 40.5 | 41.7 | 40.5 | 41.4 | 38.4 | 33.5 | 49.5 | 32.8 |
| Research and development | 0.1 | 0.2 | 0.2 | 0.1 | 0.2 | 0.5 | 0.8 | 0.4 |
| Equity in earnings | | | | | | | | |
| Other operating expenses | 5.4 | 12.6 | -4.0 | -31.1 | -44.2 | 20.7 | -15.3 | -10.9 |
| EBITDA [+] | | -10.6 | | -0.2 | 17.3 | -9.9 | -4.5 | 14.5 |
| EBITDA growth | -104.7% | 6.6% | -399.2% | -101.1% | -558.0% | -28.7% | -277.9% | -287.1% |
| EBITDA margin | -0.4% | -7.4% | 8.7% | -0.1% | 11.4% | -6.4% | -2.7% | 10.2% |
| Depreciation | | -34.1 | | 40.8 | 12.7 | -39.3 | 39.3 | 24.5 |
| EBITA | -0.6 | 23.5 | 13.3 | -40.9 | 4.5 | 29.4 | -43.8 | -10.1 |
| EBITA margin | -0.4% | 16.3% | 8.7% | -26.7% | 3.0% | 18.9% | -26.1% | -7.1% |
| Amortization of intangibles | 30.8 | 67.4 | 34.1 | | 24.3 | 76.8 | | |
| EBIT [+] | -31.4 | -43.9 | -20.7 | -40.9 | -19.8 | -47.4 | -43.8 | -10.1 |
| EBIT growth | 51.5% | -7.4% | -52.7% | 306.2% | -17.8% | 82.6% | 416.8% | -11.4% |
| EBIT margin | -17.8% | -30.5% | -13.5% | -26.7% | -13.0% | -30.6% | -26.1% | -7.1% |
| Non-recurring items [+] | 2.9 | 7.9 | 0.4 | 426.5 | | 8.1 | 25.6 | 63.6 |
| Restructuring charges | 0.9 | 5.1 | | | | 7.0 | 24.4 | |
| Legal settlement | 2.0 | 2.8 | 0.4 | | | 1.1 | 1.2 | |
| Interest expense, net [+] | 9.8 | 3.1 | 4.4 | 5.5 | 2.3 | 9.9 | 10.2 | 9.5 |
| Interest expense | 9.8 | 3.1 | 4.4 | 17.3 | 2.3 | 9.9 | 10.2 | 12.4 |
| Interest income | | | | 11.7 | | | | 2.9 |
| Other income (expense), net [+] | -4.4 | -18.5 | -33.0 | 11.3 | 72.7 | 65.6 | 49.7 | 121.5 |
| Change in fair value of warrants | 8.2 | 0.0 | -1.5 | -5.1 | -21.1 | -20.2 | -17.5 | -1.2 |
| Pre-tax income | -48.6 | -73.3 | -58.6 | -461.6 | 50.6 | 0.1 | -29.8 | 38.4 |
| Income taxes | 7.3 | -11.7 | 7.2 | -3.8 | -1.8 | -5.7 | 4.8 | 4.7 |
| Tax rate | | 16.0% | | 0.8% | | | | 12.3% |
| Minority interest | 15.7 | 7.8 | 7.7 | 20.3 | 9.3 | 6.0 | 7.0 | -6.7 |
| Net income | -71.5 | -69.5 | -73.5 | -478.1 | 43.2 | -0.2 | -41.6 | 40.3 |
| Net margin | -40.4% | -48.2% | -48.0% | -311.8% | 28.4% | -0.1% | -24.8% | 28.4% |
| |
| Basic EPS [+] | ($0.10) | ($0.11) | ($0.13) | ($0.99) | $0.09 | $0.00 | ($0.09) | $0.15 |
| Growth | -19.0% | 25902.1% | 37.8% | -763.9% | -108.6% | -99.9% | -34.7% | -138.4% |
| Diluted EPS [+] | ($0.10) | ($0.11) | ($0.13) | ($0.99) | $0.09 | $0.00 | ($0.09) | $0.15 |
| Growth | -19.0% | 25902.1% | 37.8% | -763.9% | -108.6% | -99.9% | -34.7% | -138.4% |
| |
| Shares outstanding (basic) [+] | 691.2 | 611.7 | 575.3 | 481.2 | 485.7 | 460.3 | 449.4 | 269.5 |
| Growth | 20.1% | 32.9% | 28.0% | 78.5% | 83.0% | 89.0% | 85.7% | 24.7% |
| Shares outstanding (diluted) [+] | 691.2 | 611.7 | 575.3 | 481.2 | 488.5 | 460.3 | 449.4 | 269.5 |
| Growth | 20.1% | 32.9% | 28.0% | 78.5% | 84.1% | 89.0% | 85.7% | 24.7% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |